PDGFRα/β expression correlates with the metastatic behavior of human colorectal cancer: A possible rationale for a molecular targeting strategy

Carl Christoph Schimanski(Johannes Gutenberg University Mainz)

Oncology Reports

March 1, 2008

10.3892/or.19.3.697

Cited by 37

Related Papers

Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

|Nature Cancer|2022|62

Anti-SARS-CoV-2 antibody containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 via increased neutralizing antibody activity – a randomized clinical trial

|medRxiv|2022|4

Contents Vol. 48, 2012

|European Surgical Research|2012|0

1142. Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial

|Open Forum Infectious Diseases|2022|0